GRAIL to Announce Second Quarter 2025 Financial Results

Rhea-AI Summary

GRAIL (Nasdaq: GRAL), a healthcare company focused on early cancer detection, will release its Q2 2025 financial results on Tuesday, August 12, 2025 after market close. Management will host a conference call and webcast at 1:30 PM PT / 4:30 PM ET to discuss the results and business progress.

Interested parties can access the live webcast through GRAIL's investor relations website at investors.grail.com. Participants are advised to register at least ten minutes before the call's scheduled start time through the provided registration link.

News Market Reaction – GRAL

-1.03%

30 alerts

-1.03% News Effect

-5.1% Trough in 2 hr 6 min

-$13M Valuation Impact

$1.28B Market Cap

0.8x Rel. Volume

On the day this news was published, GRAL declined 1.03%, reflecting a mild negative market reaction. Argus tracked a trough of -5.1% from its starting point during tracking. Our momentum scanner triggered 30 alerts that day, indicating elevated trading interest and price volatility. This price movement removed approximately $13M from the company's valuation, bringing the market cap to $1.28B at that time.

Data tracked by StockTitan Argus on the day of publication.

MENLO PARK, Calif., July 29, 2025 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, announced today that it will issue financial results for the second quarter 2025 following the close of market on Tuesday, Aug. 12, 2025. Following the release, company management will host a webcast and conference call at 1:30 p.m. PT / 4:30 p.m. ET to discuss results and business progress.

Second Quarter 2025 Webcast and Conference Call Details
A link to the live webcast and recorded replay will be available at the investor relations section of GRAIL's website at investors.grail.com.  

Please register for the live event at https://grail-q2-financial-results-2025.open-exchange.net/.

To ensure timely connection, please register for the teleconference and join the webcast at least ten minutes before the scheduled start of the call. The live webcast and recorded replay are open to all interested parties.

About GRAIL
GRAIL is a healthcare company whose mission is to detect cancer early, when it can be cured. GRAIL is focused on alleviating the global burden of cancer by using the power of next-generation sequencing, population-scale clinical studies, and state-of-the-art machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages. GRAIL's targeted methylation-based platform can support the continuum of care for screening and precision oncology, including multi-cancer early detection in symptomatic patients, risk stratification, minimal residual disease detection, biomarker subtyping, treatment and recurrence monitoring. GRAIL is headquartered in Menlo Park, CA with locations in Washington, D.C., North Carolina, and the United Kingdom.

For more information, visit grail.com.

View original content to download multimedia:https://www.prnewswire.com/news-releases/grail-to-announce-second-quarter-2025-financial-results-302516336.html

SOURCE GRAIL, Inc.

FAQ

When will GRAIL (GRAL) release Q2 2025 earnings?

GRAIL will release Q2 2025 financial results on Tuesday, August 12, 2025 after market close.

What time is GRAIL's Q2 2025 earnings call?

GRAIL's Q2 2025 earnings call is scheduled for 1:30 PM PT / 4:30 PM ET on August 12, 2025.

How can I access GRAIL's Q2 2025 earnings call?

You can access the live webcast through GRAIL's investor relations website at investors.grail.com or register at the provided link. Registration should be completed at least 10 minutes before the call.

What is GRAIL's main business focus?

GRAIL is a healthcare company focused on early cancer detection with the mission of detecting cancer early when it can be cured.